• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Aethlon to provide Hemopurifier to treat Ebola in U.S.

Aethlon to provide Hemopurifier to treat Ebola in U.S.

October 29, 2014 By Val Kennedy

Aethlon to provide Hemopurifier to treat Ebola in U.S.

Aethlon Medical (OTC:AEMD) said that it plans to make its Hemopurifier blood-filtration device available to U.S. healthcare providers for the treatment of Ebola under the FDA’s compassionate use provision.

"Based on guidance from FDA, the treatment of Ebola virus infection provides for a unique circumstance where a physician or healthcare provider may wish to pursue the compassionate use of Hemopurifier therapy based on the serious nature of the disease and absence of alternative therapies," according to a press release.

"Compassionate use provisions are typically approved by FDA on an individual patient basis, but may be expanded to include a small group," Aethlon added.

In mid-October, Aethlon revealed Hemopurifier was being used to treat an Ebola patient hospitalized in Frankfurt, Germany. Aethlon is planning to submit treatment data to the FDA in hopes of expanding use of the device under the agency’s emergency use provision.

“The administration of Hemopurifier therapy in Germany has reinforced the need to clarify defined regulatory pathways that might allow us to treat Ebola infection in the United States," founder & CEO Jim Joyce said in a statement. "As it relates to the patient treated in Germany, we respect patient confidentiality and will report on his response to therapy after Frankfurt University Hospital officials provide an update on his condition."

Aethlon added that it plans to initiate U.S. clinical testing of the device under a previously filed investigational device exemption. Last year, the FDA approved IDE testing of the product for the treatment of hepatitis C.

Laboratory studies have shown Hemopurifier can be effective in filtering such dangerous viral pathogens as Ebola, Dengue, avian flu and West Nile, Aethlon said.

Filed Under: Food & Drug Administration (FDA), News Well Tagged With: Aethlon Medical Inc., Ebola, Investigational Device Exemption (IDE)

More recent news

  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment
  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit
  • Medtronic issues safety notice for Hugo surgical robot console in Europe

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy